<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020542/" ref="ordinalpos=3017&amp;ncbi_uid=6169408&amp;link_uid=PMC4020542" image-link="/pmc/articles/PMC4020542/figure/fig5/" class="imagepopup">Figure 5.  From: Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLCγ2-PKC and MAPK Pathways . </a></div><br /><div class="p4l_captionBody">Hypothesis regarding the inhibitory signaling of amarogentin in platelet activation. Amarogentin may inhibit both the PLCγ2-PKC-p47 cascades and MAPK signaling pathway, ultimately inhibiting platelet activation. DAG: diacylglycerol; IP3: inositol 1,4,5-trisphosphate.</div></div>